Related Experiment Videos

Combination therapy for kidney protection in type 1 diabetes mellitus: quo vadis?

Djordje S Popovic¹, Dimitrios Patoulias², Theocharis Koufakis²

¹Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Centre of Vojvodina, Medical Faculty, University of Novi Sad, Novi Sad, Serbia.

Diabetes Research and Clinical Practice

|February 19, 2026

Abstract

No abstract available in PubMed .

Keywords:

Chronic kidney disease Combination therapy Type 1 diabetes mellitus

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cardiovascular risk assessment in adults with type 1 diabetes: A cross-sectional comparison of two prediction models.

Biomolecules & biomedicine·2026

Cardiovascular-kidney-metabolic syndrome: definition, staging, diagnosis and therapeutic management. An expert consensus statement of the Committee of cardiovascular-kidney-metabolic syndrome of the Hellenic Society of Cardiology.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026

Secondary Hemophagocytic Lymphohistiocytosis Triggered by Visceral Leishmaniasis Due to Leishmania infantum: A Case Report.

Reports (MDPI)·2026

Reappraisal of GLP-1 receptor agonists in older adults.

Trends in endocrinology and metabolism: TEM·2026

Chronic Kidney Disease-Associated Cardiomyopathy: Mechanisms and Therapeutic Strategies.

British journal of hospital medicine (London, England : 2005)·2026

Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023.

JAMA·2026

See all related articles